LMWH has advantages over HMWH. LMWH has a lower molecular weight which allows it to be more bioavailable and predictable after subcutaneous injection compared to HMWH. Both are anticoagulants used to treat and prevent blood clots, but LMWH has advantages in terms of its mechanism of action and pharmacokinetic profile due to its lower molecular weight.